EMZ Partners is acquiring a minority stake in Almerys to accelerate its growth and technological innovation within the insurance sector in France.
Target Company Overview
Almerys is a key player in the French insurance ecosystem, recognized as a reliable third party for mutual insurers, private insurers, bank insurers, and provident institutions. The company specializes in providing comprehensive solutions designed to digitize and secure the business processes associated with managing and processing insurance operations. With revenues exceeding €60 million, Almerys boasts a diverse portfolio of services, including data processing, care reimbursements, compliance management, and contract management services.
Almerys stands out in the market due to its unique ability to offer a holistic suite of services. The firm manages health protection claims, making it possible to process nearly €8 billion in transaction flows annually for private insurance clients and their collective 16 million customers. Moreover, Almerys is equipped with the largest active contracting network in the healthcare sector, encompassing over 300,000 partner healthcare professionals. Their latest advancements incorporate AI technology for automatic fraud detection and efficient hospital invoice management, alongside a fully digitized services platform and secure hosting for insured health data.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The French insurance industry is undergoing a significant digital transformation, driven by advances in technology and changing consumer behavior. Insurers increasingly seek innovative solutions to enhance operational efficiency and customer engagement. The recent su
Similar Deals
Capital Croissance → Aether Financial Services
2024
Banque des Territoires → GENEO Capital
2023
EMZ Partners
invested in
Almerys
in 2023
in a Growth Equity & Expansion Capital deal
Disclosed details
Revenue: $60M